Forecast: Musculo-Skeletal System Medicine Sales in Canada

The forecast for musculo-skeletal system medicine sales in Canada shows a slight annual decrease of 0.44% from 2024 to 2028, as US dollars per capita values drop incrementally from 22.8 in 2024 to 22.4 by 2028. The compound annual growth rate (CAGR) over the five-year period suggests a declining trend, following the 2023 per capita value baseline. The consistent decline suggests shifts in market dynamics or improvements in treatment methodologies reducing medication reliance.

Future trends to watch include:

• The impact of new musculo-skeletal therapies and technological advancements.
• Healthcare policy changes affecting drug pricing and accessibility.
• Demographic shifts in Canada's aging population influencing demand.